AC Immune
ACIU • NASDAQ
AC Immune is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Andrea Pfeifer, with a market cap of $346.0M.
Market Cap$346.0M
Employees161.0
CEOAndrea Pfeifer
CountrySwitzerland
Healthcare
Biotechnology
Next EarningsApr 29, 2026 · In 2 weeksQ1 2026
Financials
AC Immune FAQ
Common questions about AC Immune
AC Immune is scheduled to report earnings for Q1 2026 on April 29, 2026. Analysts estimate revenue of $1.0M.
AC Immune has approximately 161 employees.